The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation

Detalles Bibliográficos
Autores principales: Khorana, Alok A., McCrae, Keith, Milentijevic, Dejan, McCormick, Nora, Laliberté, François, Crivera, Concetta, Lefebvre, Patrick, Lejeune, Dominique, Rozjabek, Heather, Schein, Jeff, Streiff, Michael B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
E‐only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590399/
https://www.ncbi.nlm.nih.gov/pubmed/30474161
http://dx.doi.org/10.1002/ajh.25361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590399/
https://www.ncbi.nlm.nih.gov/pubmed/30474161
http://dx.doi.org/10.1002/ajh.25361

Ejemplares similares